Mouse bone-marrow-derived DCs first activated with the TLR4 ligand LPS and exposed to tumor-induced Treg maintain expression of CD80, CD86, and CD40, produce IL-12 or TNF-a, and are not impaired in their allostimulatory activity [48]. The gene discussed is CD80; the disease is neoplasm.